InduPro

InduPro is a biotechnology company dedicated to defining and harnessing the inherent and induced proximity biology to unlock next-generation therapies for cancer and autoimmune diseases. The company develops treatments targeting novel tumor-selective targets and co-target pairs using bispecific antibodies, including antibody-drug conjugates (ADCs) and T-cell engagers (TCEs), thereby driving a robust pipeline of first-in-class and best-in-class programs.